IP Library Granted Patent US 11,001,887
Granted Patent B2
US 11,001,887 · App. 16/430,064 · Granted May 11, 2021

Methods and compositions for incorporating nucleotides

Inventors: Steven Gordon (Weston, MA); Jerzy Olejnik (Brookline, MA)
Assignee: QIAGEN SCIENCES, LLC
C12Q1/6869C07H19/00C12Q1/6874G01N21/05G01N21/645G01N21/6428C12Q2535/101G01N2021/0346G01N2021/058G01N2021/6417G01N2021/6419G01N2021/6421G01N2021/6439G01N2021/6441G01N2021/6471G01N2201/062G01N2201/0627G01N2201/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,001,887
App. No.
16/430,064
Granted
May 11, 2021
Kind
B2
Abstract

The invention provides methods and compositions, including, without limitation, algorithms, computer readable media, computer programs, apparatus, and systems for determining the identity of nucleic acids in nucleotide sequences using, for example, data obtained from sequencing by synthesis methods. The methods of the invention include correcting one or more phenomena that are encountered during nucleotide sequencing, such as using sequencing by synthesis methods. These phenomena include, without limitation, sequence lead, sequence lag, spectral crosstalk, and noise resulting from variations in illumination and/or filter responses.

Claims (13)

1. A method of incorporating labeled nucleotides into nucleic acid, comprising:

a) providing a plurality of nucleic acid template molecules, a polymerase, a cleaving agent, and a mixture of labeled and non-labeled reversible nucleotide analogue terminators, said labeled reversible nucleotide analogue terminators comprising a label linked to a nucleotide analogue, said label producing color, wherein said labeled reversible nucleotide analogues are labeled with at least one type of fluorescent dye; wherein each reversible terminator contains a reversibly removable chemical moiety capping the 3′-OH group;

b) incorporating a first labeled nucleotide analogue with said polymerase;

c) detecting color of said at least one type of fluorescent dye of the incorporated nucleotide analogue in two channels;

d) removing i) said label of the incorporated nucleotide analogue and ii) said reversibly removable chemical moiety capping the 3′-OH group, with said cleaving agent; and

e) incorporating a second nucleotide analogue.

2. The method of claim 1 , wherein said label and said chemical moiety capping the 3′-OH group are removed at the same time.

3. The method of claim 1 , wherein said at least one type of fluorescent dye is visible in the yellow channel and the green channel.

4. The method of claim 1 , wherein said at least one type of fluorescent dye is visible in the red channel and the green channel.

5. The method of claim 1 , wherein said at least one type of fluorescent dye is visible in the blue channel and the red channel.

6. The method of claim 1 , wherein said non-labeled nucleotides are employed in ratios between 10:1 and 100:1 relative to the labeled nucleotides.

7. The method of claim 1 , wherein said mixture of labeled and non-labeled reversible nucleotide analogues is reversibly terminated by a disulfide bond at the 3′ position.

8. The method of claim 1 , wherein said mixture of labeled and non-labeled reversible terminators is reversibly terminated by an azidomethyl group at the 3′ position.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Mar 24, 2023
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: ISOPLEXIS CORPORATION
Reel/Frame 063235/0942 →
PATENT PURCHASE AGREEMENT Recorded Jul 30, 2021
From: QIAGEN SCIENCES, LLC
To: ISOPLEXIS CORPORATION
Reel/Frame 057043/0629 →
SECURITY AGREEMENT Recorded May 28, 2021
From: ISOPLEXIS CORPORATION
To: PERCEPTIVE CREDIT HOLDINGS III, LP
Reel/Frame 056421/0929 →
MERGER Recorded Sep 12, 2019
From: QIAGEN WALTHAM, INC.
To: QIAGEN SCIENCES, LLC
Reel/Frame 050354/0701 →
CHANGE OF NAME Recorded Sep 11, 2019
From: INTELLIGENT BIO-SYSTEMS, INC.
To: QIAGEN WALTHAM, INC.
Reel/Frame 050343/0346 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2019
From: GORDON, STEVEN; OLEJNIK, JERZY
To: INTELLIGENT BIO-SYSTEMS, INC.
Reel/Frame 049408/0927 →
Continuity (7)
Continuation 15911801 · Mar 5, 2018
Continuation 15214737 · Jul 20, 2016
Continuation 14691042 · Apr 20, 2015
Continuation 13305415 · Nov 28, 2011
Continuation 12405779 · Mar 17, 2009
Provisional Application 61037845 · Mar 19, 2008
Related Publication 20200040391A1 · Feb 6, 2020
Cited By (2)
US 12,227,798 US 12,656,313